IDEXX Labs (IDXX) reported Q4 EPS of $2.05, $0.13 better than the analyst estimate of $1.92. Revenue for the quarter came in at $829 million versus the consensus estimate of...
Investing.com - IDEXX Labs (NASDAQ: IDXX) reported fourth quarter EPS of $2.05, $0.13 better than the analyst estimate of $1.92. Revenue for the quarter came in at $829M versus the...
Markets are set for a volatile month, as a plethora of important economic decisions line up However, investors should keep in mind that short-term volatility does not imply bad...
Many people have marked Valentine's Day, Feb. 14, on their calendars. The annual festivity has evolved to one of the year’s most lucrative shopping seasons in the US....
So far in 2021, consumer spending in the U.S has been strong. According to the metrics released Aug. 31, the Conference Board Consumer Confidence Index was “113.8, down from...
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
|Average||566.71 (+14.82% Upside)|
|No. of Analysts||7|
|Moving Averages||Sell||Neutral||Buy||Strong Buy||Strong Buy|
|Technical Indicators||Strong Sell||Sell||Strong Buy||Strong Buy||Strong Buy|
|Summary||Strong Sell||Neutral||Strong Buy||Strong Buy||Strong Buy|